eFilm Workstation 4.0 and 4.0.1. eFilm Workstation is one of the components of a PACS (Picture A...

FDA Device Recall #Z-0068-2015 — Class II — August 28, 2014

Recall Summary

Recall Number Z-0068-2015
Classification Class II — Moderate risk
Date Initiated August 28, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Merge Healthcare, Inc.
Location Hartland, WI
Product Type Devices
Quantity 2,630

Product Description

eFilm Workstation 4.0 and 4.0.1. eFilm Workstation is one of the components of a PACS (Picture Archiving and Communications System). Product Usage: eFilm Workstation is a software application that is used for viewing medical images. eFilm Workstation receives digital images and data from various sources (including but not limited to CT,MR, US, RF units, computed and direct radiographic devices, secondary capture devices, scanners, imaging gateways or imaging sources). Images are stored, communicated, processed and displayed on the local disc of a workstation and/or across computer networks at distributed locations. Tasks that users may perform when viewing images include, but are not limited to: adjustment of window width and level; image stacking; annotation and measurement of regions of interest; and inversion, rotation, and flips of images. In addition, eFilm Workstation can be integrated with an institution s existing HIS or RIS for a fully integrated electronic patient record.

Reason for Recall

There is an issue related to eFilm Workstation versions 4.0 and 4.0.1 when having multiple studies open and utilizing the thumbnail panel to select multiple series from multiple studies may lead to the selection of an incorrect study.

Distribution Pattern

Worldwide Distribution - US Nationwide and the countries of : Argentina, Australia, Canada, Chile, France, Germany, Hungary, Iceland, Italy, Lithuania, Mexico, New Zealand, Romania, Russia, South Africa, Sweden, and Yemen.

Lot / Code Information

versions 4.0 and 4.0.1

Other Recalls from Merge Healthcare, Inc.

Recall # Classification Product Date
Z-2518-2025 Class II Merge Hemo, Model RCSV2, Model/Catalog Number 9... Aug 11, 2025
Z-1399-2025 Class II VERICIS, Merge Cardio, Model/Catalog Number: Ve... Feb 19, 2025
Z-1402-2025 Class II Merge Cardio, Model/Catalog Number: Version 12.... Feb 19, 2025
Z-1400-2025 Class II VERICIS, Merge Cardio, Model/Catalog Number: Ve... Feb 19, 2025
Z-1398-2025 Class II VERICIS, Merge Cardio, Model/Catalog Number: Ve... Feb 19, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.